# FDA recall D-1817-2015

> **Allergan Sales, LLC** · Class II · drug recall initiated 2015-08-24.

## Product

Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant Eye Ointment, packaged in a) Net wt. 0.12 oz (3.5 g) tubes (NDC 0023-0312-04) UPC 3 0023-0312-04 2 and b) Net wt. 0.25 oz (7 g) tubes (NDC 0023-0312-07) UPC 3 0023-0312-07 3, Allergan, Inc., 2525 Dupont Drive, Irvine, CA  92612.

## Reason for recall

Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.

## Distribution

Nationwide, Puerto Rico, and Barbados

## Key facts

- **Recall number:** D-1817-2015
- **Recalling firm:** Allergan Sales, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-08-24
- **Report date:** 2015-09-30
- **Termination date:** 2017-04-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Waco, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1817-2015

## Citation

> AI Analytics. FDA recall D-1817-2015. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-1817-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*